Background: Post-psychotic depression (PPD) is an important and frequent clinical
phenomenon featuring controversial complexity in its nosological and aetiopathogenic …

Background Depressive symptoms are frequent in schizophrenia and associated with a
poorer outcome. Currently, the optimal treatment for depressive symptoms in schizophrenia …

Depression occurs frequently in all phases of schizophrenia spectrum disorders. Altered
activity in the immune system is seen in both depression and schizophrenia. We aimed to …

Depressive symptoms are common in schizophrenia and have been associated with both
favourable and unfavourable outcomes. We studied the longitudinal course of depressive …

Background Impulsivity is a transdiagnostic feature linked to severe clinical expression and
a potential target for psychopharmacological strategies. Biological underpinnings are largely …

BACKGROUND Antipsychotic drugs remain the mainstay of schizophrenia treatment;
however, their effectiveness has been questioned, and it is not possible to predict the …

Agitation is a state of restlessness and excessive psychomotor activity accompanied by
anxiety, irritability, and impaired impulse control. Despite that agitation is a particularly …

Abstract ENGLISH SUMMARY: The period surrounding the first episode of psychosis
represents a critical period in the natural course of the illness. There are several studies on …

Background The prevalence of new psychoactive substances (NPS) in acute psychotic
patients has not been investigated systematically. We applied a highly sensitive and specific …

Aim: The aim of this study is to compare the effectiveness and safety of aripiprazole and
amisulpiride as additional treatments to olanzapine in individuals with schizophrenia who …